EU medicines agency quits X, moves to Bluesky
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...
Pharm Exec3d
EMA Takes Break From X, Joins Bluesky
The government agency says X no longer suits its communication needs.
Hosted on MSN10mon
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
This delay, attributed to procedural issues at the European Medicines Agency (EMA), has implications for the review process of lecanemab, a pivotal drug currently under EMA evaluation. Also Read ...
TCTMD9d
European Medicines Agency Investigating GLP-1 Drugs and Eye Disease
A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.
Nature3mon
A European perspective on immunogenicity evaluation
Although the perceived risk is likely to affect the choice of evaluation approach ... on the other hand. European Medicines Agency. Guideline on Immunogenicity Assessment of Biotechnology-derived ...
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
Submission supported by positive results from global, Phase 3 4WHIM clinical trial;U.S. regulatory approval in WHIM syndrome granted in ...
The Straits Times3d
EU medicines agency quits X, moves to Bluesky
EMA is a decentralised agency of the European Union, responsible for the scientific evaluation, supervision and safety monitoring of medicines. Its headquarters is in Amsterdam, the Netherlands.
AOL3d
EU medicines agency quits X, moves to Bluesky
AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would ... responsible for the scientific evaluation, supervision and safety monitoring of medicines.